Study of APD421 as PONV Treatment (no Prior Prophylaxis)

NCT02449291 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
568
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Acacia Pharma Ltd